Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Change in Intangibles (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Change in Intangibles for 16 consecutive years, with $43842.0 as the latest value for Q4 2025.

  • Quarterly Change in Intangibles rose 78.76% to $43842.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $84402.0 through Dec 2025, down 25.47% year-over-year, with the annual reading at $84402.0 for FY2025, 25.47% down from the prior year.
  • Change in Intangibles hit $43842.0 in Q4 2025 for Cumberland Pharmaceuticals, up from $8449.0 in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $1.8 million in Q4 2022 to a low of $8449.0 in Q3 2025.
  • Historically, Change in Intangibles has averaged $129601.5 across 5 years, with a median of $36690.0 in 2022.
  • Biggest five-year swings in Change in Intangibles: soared 2451.73% in 2022 and later crashed 97.88% in 2023.
  • Year by year, Change in Intangibles stood at $70317.0 in 2021, then skyrocketed by 2451.73% to $1.8 million in 2022, then plummeted by 97.88% to $38044.0 in 2023, then plummeted by 35.53% to $24526.0 in 2024, then skyrocketed by 78.76% to $43842.0 in 2025.
  • Business Quant data shows Change in Intangibles for CPIX at $43842.0 in Q4 2025, $8449.0 in Q3 2025, and $13912.0 in Q2 2025.